Provided by Tiger Trade Technology Pte. Ltd.

Puma Biotechnology

6.88
-0.0600-0.86%
Post-market: 7.000.1200+1.74%19:28 EST
Volume:410.78K
Turnover:2.82M
Market Cap:346.69M
PE:9.24
High:6.98
Open:6.88
Low:6.76
Close:6.94
52wk High:7.29
52wk Low:2.58
Shares:50.39M
Float Shares:38.56M
Volume Ratio:0.79
T/O Rate:1.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7442
EPS(LYR):0.6224
ROE:39.69%
ROA:9.90%
PB:3.01
PE(LYR):11.05

Loading ...

Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Sep 16, 2024

Major Issues Report

Form 8-K - Current report